Search Results - Richard M. Sherry
- Showing 1 - 20 results of 57
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer by James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg
Published 2003Artigo -
7
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma by Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg
Published 2010Artigo -
8
High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma by Jacob A. Klapper, Stephanie G. Downey, Franz O. Smith, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Richard E. Royal, Seth M. Steinberg, Steven A. Rosenberg
Published 2008Artigo -
9
Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL by Stephanie L. Goff, Franz O. Smith, Jacob A. Klapper, Richard M. Sherry, John R. Wunderlich, Seth M. Steinberg, Donald White, Steven A. Rosenberg, Mark E. Dudley, James C. Yang
Published 2010Artigo -
10
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy by James N. Kochenderfer, Robert Somerville, Tangying Lu, James C. Yang, Richard M. Sherry, Steven A. Feldman, Lori McIntyre, Adrian Bot, John M. Rossi, Norris Lam, Steven A. Rosenberg
Published 2017Artigo -
11
Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases by Gautam U. Mehta, Parisa Malekzadeh, Thomas E. Shelton, Donald E. White, John A. Butman, James Chih‐Hsin Yang, Udai S. Kammula, Stephanie L. Goff, Steven A. Rosenberg, Richard M. Sherry
Published 2018Artigo -
12
Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with respo... by Barbara A. Pockaj, Richard M. Sherry, John P. Wei, John R. Yannelli, Charles S. Carter, Susan F. Leitman, Jorge A. Carasquillo, Seth M. Steinberg, Steven A. Rosenberg, James Chih‐Hsin Yang
Published 1994Artigo -
13
Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer by Joseph Blansfield, Kimberly E Beck, Khoi Tran, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Suzanne L. Topalian, Leah Haworth, Catherine Lévy, Steven A. Rosenberg, Richard M. Sherry
Published 2005Artigo -
14
Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans by Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula
Published 2014Artigo -
15
T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study by Stacey L. Doran, Sanja Stevanović, Sabina Adhikary, Jared J. Gartner, Li Jia, Mei Li M. Kwong, William C. Faquin, Stephen M. Hewitt, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Christian S. Hinrichs
Published 2019Artigo -
16
Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis by James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, Suzanne L. Topalian, Kimberly B. Suri, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Israel Lowy, Donald E. White, Steven A. Rosenberg
Published 2007Artigo -
17
Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma by Ajay V. Maker, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Marybeth S. Hughes, Michael Yellin, Leah Haworth, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Peter Attia, Steven A. Rosenberg
Published 2006Artigo -
18
Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen by Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, Linda J. Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White
Published 2003Artigo -
19
Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines by Franz O. Smith, Stephanie G. Downey, Jacob A. Klapper, James C. Yang, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Catherine Lévy, Donald E. White, Seth M. Steinberg, Steven A. Rosenberg
Published 2008Artigo -
20
Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study by Ajay V. Maker, Giao Q. Phan, Peter Attia, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Leah Haworth, Catherine Lévy, David E. Kleiner, Sharon Mavroukakis, Michael Yellin, Steven A. Rosenberg
Published 2005Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Immunology
Cancer research
Cancer
Immune system
Melanoma
Oncology
Immunotherapy
T cell
Gastroenterology
Antigen
Adoptive cell transfer
Biology
Chemotherapy
Surgery
Biochemistry
CD8
Cyclophosphamide
Chimeric antigen receptor
Fludarabine
In vitro
Pathology
Antibody
Cytotoxic T cell
Clinical trial
Ipilimumab
Metastatic melanoma
Receptor
Regimen